title: Response phenotype as a predictive biomarker to guide treatment with targeted therapies.
authors.affiliation: Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
authors.forename: Geoffrey R
authors.initials: GR
authors.lastname: Oxnard
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Schwartz
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab